Aktis Oncology Inc. increased the size of its initial public offering by 50%, and drew interest from Eli Lilly & Co. for $100 million of shares in the listing.
Sign in to read the full article.
Sign in with Google
Aktis Oncology Inc. increased the size of its initial public offering by 50%, and drew interest from Eli Lilly & Co. for $100 million of shares in the listing.
Sign in to read the full article.
Sign in with Google